Back to Search
Start Over
Type 1 diabetes in a melanoma patient treated with ipilimumab after nivolumab.
- Source :
-
The Journal of dermatology [J Dermatol] 2018 Oct; Vol. 45 (10), pp. e289-e290. Date of Electronic Publication: 2018 Apr 18. - Publication Year :
- 2018
- Subjects :
- Antineoplastic Agents, Immunological administration & dosage
Antineoplastic Combined Chemotherapy Protocols administration & dosage
Blood Glucose analysis
Diabetes Mellitus, Type 1 blood
Diabetes Mellitus, Type 1 diagnosis
Diabetes Mellitus, Type 1 immunology
Female
Humans
Ipilimumab administration & dosage
Melanoma drug therapy
Middle Aged
Nivolumab administration & dosage
Skin Neoplasms drug therapy
Antineoplastic Agents, Immunological adverse effects
Antineoplastic Combined Chemotherapy Protocols adverse effects
Diabetes Mellitus, Type 1 chemically induced
Ipilimumab adverse effects
Nivolumab adverse effects
Subjects
Details
- Language :
- English
- ISSN :
- 1346-8138
- Volume :
- 45
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- The Journal of dermatology
- Publication Type :
- Report
- Accession number :
- 29667767
- Full Text :
- https://doi.org/10.1111/1346-8138.14331